Report Detail
Global Terbinafine Hydrochloride Drug Market Insights, Forecast to 2025
- RnM3542134 |
- 19 June, 2019 |
- Global |
- 126 Pages |
- QYResearch |
- Pharma & Healthcare
Terbinafine, sold under the brand name Lamisil among others, an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm including jock itch and athlete's foot. It is either taken by mouth or applied to the skin as a cream or ointment. The cream and ointment are not effective for nail infections.
The global Terbinafine Hydrochloride Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Terbinafine Hydrochloride Drug market based on company, product type, end user and key regions.
This report studies the global market size of Terbinafine Hydrochloride Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Terbinafine Hydrochloride Drug in these regions.
This research report categorizes the global Terbinafine Hydrochloride Drug market by top players/brands, region, type and end user. This report also studies the global Terbinafine Hydrochloride Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
GSK
TEVA
Dr. Reddy's Laboratories
CIPLA LTD
TARO
InvaGen Pharmaceuticals
Breckenridge Pharmaceutical
Harris Pharmaceutical
Glenmark
Orchid Healthcare
APOTEX
Jilin Wantong Group
Cussess
Hubei Hengan Fulin Pharm
Xiuzheng Pharmaceutical
Market size by Product
Topical
Oral
Market size by End User
Athlete's Foot
Jock Itch
Ringworm
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Terbinafine Hydrochloride Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Terbinafine Hydrochloride Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Terbinafine Hydrochloride Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Terbinafine Hydrochloride Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Terbinafine Hydrochloride Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Terbinafine Hydrochloride Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Terbinafine Hydrochloride Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Product
- 1.4.2 Topical
- 1.4.3 Oral
- 1.5 Market by End User
- 1.5.1 Global Terbinafine Hydrochloride Drug Market Size Growth Rate by End User
- 1.5.2 Athlete's Foot
- 1.5.3 Jock Itch
- 1.5.4 Ringworm
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Terbinafine Hydrochloride Drug Market Size
- 2.1.1 Global Terbinafine Hydrochloride Drug Revenue 2014-2025
- 2.1.2 Global Terbinafine Hydrochloride Drug Sales 2014-2025
- 2.2 Terbinafine Hydrochloride Drug Growth Rate by Regions
- 2.2.1 Global Terbinafine Hydrochloride Drug Sales by Regions
- 2.2.2 Global Terbinafine Hydrochloride Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Terbinafine Hydrochloride Drug Sales by Manufacturers
- 3.1.1 Terbinafine Hydrochloride Drug Sales by Manufacturers
- 3.1.2 Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers
- 3.1.3 Global Terbinafine Hydrochloride Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Terbinafine Hydrochloride Drug Revenue by Manufacturers
- 3.2.1 Terbinafine Hydrochloride Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Terbinafine Hydrochloride Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Terbinafine Hydrochloride Drug Price by Manufacturers
- 3.4 Terbinafine Hydrochloride Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Terbinafine Hydrochloride Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Terbinafine Hydrochloride Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Terbinafine Hydrochloride Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Terbinafine Hydrochloride Drug Sales by Product
- 4.2 Global Terbinafine Hydrochloride Drug Revenue by Product
- 4.3 Terbinafine Hydrochloride Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Terbinafine Hydrochloride Drug Breakdown Data by End User
6 North America
- 6.1 North America Terbinafine Hydrochloride Drug by Countries
- 6.1.1 North America Terbinafine Hydrochloride Drug Sales by Countries
- 6.1.2 North America Terbinafine Hydrochloride Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Terbinafine Hydrochloride Drug by Product
- 6.3 North America Terbinafine Hydrochloride Drug by End User
7 Europe
- 7.1 Europe Terbinafine Hydrochloride Drug by Countries
- 7.1.1 Europe Terbinafine Hydrochloride Drug Sales by Countries
- 7.1.2 Europe Terbinafine Hydrochloride Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Terbinafine Hydrochloride Drug by Product
- 7.3 Europe Terbinafine Hydrochloride Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Terbinafine Hydrochloride Drug by Countries
- 8.1.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Countries
- 8.1.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Terbinafine Hydrochloride Drug by Product
- 8.3 Asia Pacific Terbinafine Hydrochloride Drug by End User
9 Central & South America
- 9.1 Central & South America Terbinafine Hydrochloride Drug by Countries
- 9.1.1 Central & South America Terbinafine Hydrochloride Drug Sales by Countries
- 9.1.2 Central & South America Terbinafine Hydrochloride Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Terbinafine Hydrochloride Drug by Product
- 9.3 Central & South America Terbinafine Hydrochloride Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Terbinafine Hydrochloride Drug by Countries
- 10.1.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Countries
- 10.1.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Terbinafine Hydrochloride Drug by Product
- 10.3 Middle East and Africa Terbinafine Hydrochloride Drug by End User
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Novartis Terbinafine Hydrochloride Drug Products Offered
- 11.1.5 Novartis Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Terbinafine Hydrochloride Drug Products Offered
- 11.2.5 GSK Recent Development
- 11.3 TEVA
- 11.3.1 TEVA Company Details
- 11.3.2 Company Business Overview
- 11.3.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 TEVA Terbinafine Hydrochloride Drug Products Offered
- 11.3.5 TEVA Recent Development
- 11.4 Dr. Reddy's Laboratories
- 11.4.1 Dr. Reddy's Laboratories Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Products Offered
- 11.4.5 Dr. Reddy's Laboratories Recent Development
- 11.5 CIPLA LTD
- 11.5.1 CIPLA LTD Company Details
- 11.5.2 Company Business Overview
- 11.5.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 CIPLA LTD Terbinafine Hydrochloride Drug Products Offered
- 11.5.5 CIPLA LTD Recent Development
- 11.6 TARO
- 11.6.1 TARO Company Details
- 11.6.2 Company Business Overview
- 11.6.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 TARO Terbinafine Hydrochloride Drug Products Offered
- 11.6.5 TARO Recent Development
- 11.7 InvaGen Pharmaceuticals
- 11.7.1 InvaGen Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Products Offered
- 11.7.5 InvaGen Pharmaceuticals Recent Development
- 11.8 Breckenridge Pharmaceutical
- 11.8.1 Breckenridge Pharmaceutical Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Products Offered
- 11.8.5 Breckenridge Pharmaceutical Recent Development
- 11.9 Harris Pharmaceutical
- 11.9.1 Harris Pharmaceutical Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Products Offered
- 11.9.5 Harris Pharmaceutical Recent Development
- 11.10 Glenmark
- 11.10.1 Glenmark Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Glenmark Terbinafine Hydrochloride Drug Products Offered
- 11.10.5 Glenmark Recent Development
- 11.11 Orchid Healthcare
- 11.12 APOTEX
- 11.13 Jilin Wantong Group
- 11.14 Cussess
- 11.15 Hubei Hengan Fulin Pharm
- 11.16 Xiuzheng Pharmaceutical
12 Future Forecast
- 12.1 Terbinafine Hydrochloride Drug Market Forecast by Regions
- 12.1.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Regions 2019-2025
- 12.2 Terbinafine Hydrochloride Drug Market Forecast by Product
- 12.2.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Product 2019-2025
- 12.3 Terbinafine Hydrochloride Drug Market Forecast by End User
- 12.4 North America Terbinafine Hydrochloride Drug Forecast
- 12.5 Europe Terbinafine Hydrochloride Drug Forecast
- 12.6 Asia Pacific Terbinafine Hydrochloride Drug Forecast
- 12.7 Central & South America Terbinafine Hydrochloride Drug Forecast
- 12.8 Middle East and Africa Terbinafine Hydrochloride Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Terbinafine Hydrochloride Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Terbinafine Hydrochloride Drug . Industry analysis & Market Report on Terbinafine Hydrochloride Drug is a syndicated market report, published as Global Terbinafine Hydrochloride Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Terbinafine Hydrochloride Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
